Pig cells implanted into human brain as Parkinson’s treatment

News

Author: Parkinson's Life editorsPublished: 21 June 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

A new treatment, which involves the implantation of pig cells into a human brain, is being tested as a potential treatment for Parkinson’s.

The therapy, called NTCELL, has been developed by New Zealand-based biotechnology company Living Cell Technologies, and produces factors that promote central nerve system growth and repair nerve degeneration.

Although still in the early stages of testing, the results have been promising with those being treated showing an improvement over an 18-month period.

Roger Barker, professor of Clinical Neurosciences at the University of Cambridge, said: “The strategy is a good idea. The question is how competitive that will be compared with other cell therapies.”

The treatment could be available as early as 2018.

Go Back

Share this story

Comments


Related articles


Perspectives

How this graphic novelist drew through his “intolerable Parkinson’s pain”

Cartoonist opens up about his new book - 10 years into diagnosis

READ MORE
Tom Isaacs tribute

Global update

Watch the global Parkinson’s community pay tribute to Tom Isaacs in music video

VIDEO: ‘Perfect Day’ featuring dozens of people with Parkinson’s

READ MORE
PD-Podcast-DBS

Resources & Tools

Parkinson’s podcast: DBS – a report from the front lines

Get the low-down on new surgical and non-surgical interventions

READ MORE